Northwestern Mutual Wealth Management CO Sage Therapeutics, Inc. Transaction History

Northwestern Mutual Wealth Management CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$27.52 - $37.99 $55 - $75	-2 Reduced 16.67%	10 $0
Q1 2022 May 09, 2022	SELL	$30.71 - $45.71 $5,896 - $8,776	-192 Reduced 94.12%	12 $0
Q4 2021 Feb 03, 2022	BUY	$37.06 - $47.11 $7,189 - $9,139	194 Added 1940.0%	204 $8,000
Q3 2020 Nov 13, 2020	BUY	$41.13 - $62.45 $411 - $624	10 New	10 $1,000
Q2 2020 Aug 14, 2020	SELL	$25.95 - $43.15 $1,297 - $2,157	-50 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$26.15 - $77.24 $1,307 - $3,861	50 New	50 $1,000
Q3 2019 Nov 12, 2019	SELL	$140.29 - $189.96 $1,683 - $2,279	-12 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$157.85 - $183.09 $2,209 - $2,563	-14 Reduced 53.85%	12 $2,000
Q1 2019 May 10, 2019	BUY	$89.33 - $163.65 $714 - $1,309	8 Added 44.44%	26 $4,000
Q2 2018 Aug 10, 2018	BUY	$140.36 - $175.76 $2,526 - $3,163	18 New	18 $3,000
Q3 2017 Nov 07, 2017	SELL	$61.4 - $88.52 $2,087 - $3,009	-34 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	34	34 $3,000

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $395M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.